Literature DB >> 22731644

CYP2J2 -50 G/T and ADRB2 G46A gene polymorphisms in Saudi subjects with hypertension.

Abdullah Alghasham1, Ahmad Ali, Hisham Ismail, Moataz Dowaidar, Ahmad A Settin.   

Abstract

BACKGROUND: Hypertension is a result of complex factors including multiple genetic polymorphisms.
OBJECTIVE: This study aims to check for the association of genetic polymorphisms of the cytochrome P450 2J2 (CYP 2J2) and beta-2-adrenergic receptor (ADRB2) genes with hypertension among Saudi subjects. SUBJECTS AND METHODS: This study included 116 cases with documented hypertension of at least 1 year duration. Their data were compared to that of 250 unrelated healthy nonhypertensive subjects from the same locality. For all participants, DNA was extracted and analyzed using real time polymerase chain reaction technique for the identification of genotypic and allelic variants of the CYP2J2 -50 G/T and ADRB2 G46A genes.
RESULTS: Hypertensive cases showed a significantly higher frequency of mutant CYP2J2 -50 T allele carriage (TT and GT genotypes) compared with controls (odds ratio [OR]=3.7, p=0.0003). The same was observed among subgroups of hypertension associated with diabetes and obesity (OR=3.6, p=0.007) and cases with isolated hypertension (OR=8.4, p=0.0002). On the other hand, hypertensive cases, whether being isolated or associated with obesity and/or diabetes, showed a nonsignificant difference from controls in relation to all genotypic variants related to the ADRB2 G46A polymorphism (p>0.05).
CONCLUSION: This study showed positive association of CYP2J2 gene polymorphism with hypertension among Saudi cases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22731644     DOI: 10.1089/gtmb.2012.0006

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  4 in total

1.  Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase.

Authors:  Daniel R McDougle; Amogh Kambalyal; Daryl D Meling; Aditi Das
Journal:  J Pharmacol Exp Ther       Date:  2014-10-02       Impact factor: 4.030

Review 2.  Roles of the epoxygenase CYP2J2 in the endothelium.

Authors:  Ara Askari; Scott J Thomson; Matthew L Edin; Darryl C Zeldin; David Bishop-Bailey
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-03-06       Impact factor: 3.072

Review 3.  Assessment of the environmental and genetic factors influencing prevalence of metabolic syndrome in Saudi Arabia.

Authors:  Ibrahim M Gosadi
Journal:  Saudi Med J       Date:  2016-01       Impact factor: 1.484

Review 4.  Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.

Authors:  Theresa Aliwarga; Eric A Evangelista; Nona Sotoodehnia; Rozenn N Lemaitre; Rheem A Totah
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.